Privia Health Group, Inc.

NASDAQ:PRVA

Medical - Healthcare Information Services

Healthcare
$24.60 +0.62%

+$0.15 today

Market cap
$3.14B
Beta
0.87
P/E (TTM)
134.4
EPS (TTM)
$0.18
52W Low $18.77High $26.51

Volume 2.38M

Average 0.95M

PRVA Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Privia Health Group, Inc.NASDAQ: PRVA

Revenue · Q2 FY2026 · quarter ended Jun 2026

Revenue grows, but more slowly than its trailing trend

Q2 FY2026 revenue of $632.63M rose 21.4% year over year, behind the +24.1% change in trailing-twelve-month revenue. Sequentially, it rose 4.8% from the prior quarter. Over 3 fiscal years it compounded at +16.1% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 10 analysts of $2.53B (+19.1%) for the fiscal year ending Dec 2026, a slowdown from the +22.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$632.63M+4.8% QoQ
Last fiscal yearDec 2025
$2.12B+22.3% YoY
LTMJun 2026
$2.36B+24.1% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+21.4%+5.2%-16.2 pp
1 year+22.3%+19.1%-3.1 pp
3-year CAGR+16.1%+13.2%-2.9 pp
5-year CAGR+11.2%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
2.12B USD
Year-over-year change
+22.3%
4-year CAGR
+21.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How PRVA compares with its peers on the latest reported figures

  • PRVA's LTM Jun 2026 revenue of $2.36B is the 4th highest of the 10 companies compared; the peer median is $495.59M.
  • Its year-over-year change of +24.1% is the 3rd highest of 10, against a peer median of -1.5%.
  • Over three fiscal years its annual growth of +16.1% compares with a peer median of +11.5%.
PRVA Competitors Peer median
Revenue for PRVA and competitors
Company Period LTM YoY 3-year CAGR
AGLAgilon Health, Inc.LTM Mar 2026$5.82B -2.8%+35.4%
ASTHAstrana Health, Inc.LTM Mar 2026$3.53B +56.7%+40.6%
TDOCTeladoc Health, Inc.LTM Mar 2026$2.51B -1.5%+1.7%
PRVAPrivia Health Group, Inc.LTM Jun 2026$2.36B +24.1%+16.1%
EVHEvolent Health, Inc.LTM Mar 2026$1.89B -21.3%+11.5%
PHRPhreesia, Inc.LTM Apr 2026$495.59M +14.1%+19.6%
HCATHealth Catalyst, Inc.LTM Mar 2026$302.48M -2.8%+4.0%
OMDAOmada HealthLTM Mar 2026$283.3M +49.4%+42.9%
AMWLAmerican Well CorporationLTM Mar 2026$237.38M -9.3%-3.5%
CCLDCareCloud, Inc.LTM Mar 2026$124.14M +10.3%-4.6%
Peer median (excluding PRVA) $495.59M-1.5%+11.5%

Competitors are the stored peer set for PRVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue966.22M1.36B1.66B1.74B2.12B
Cost of Revenue902.56M1.22B1.5B1.56B1.91B
Gross Profit63.66M134.78M161.5M176.85M209.43M
Gross Margin6.6%9.9%9.7%10.2%9.9%
Research & Development00000
Selling, General & Admin278.63M149.33M134.32M152.6M165.29M
Operating Expenses281.1M153.9M140.85M159.87M175.2M
Depreciation & Amortization2.46M4.57M6.53M7.27M9.91M
EBITDA(214.97M)(14.01M)35.55M35.14M53.85M
EBITDA Margin-22.2%-1.0%2.1%2.0%2.5%
Operating Income(217.44M)(19.12M)20.65M16.98M34.24M
Operating Margin-22.5%-1.4%1.2%1.0%1.6%
Interest Income0542K8.37M10.89M9.7M
Interest Expense1.07M0000
Other Income / Expenses(1.07M)542K8.37M10.89M9.7M
Income Before Tax(218.51M)(18.58M)29.02M27.87M43.94M
Pre-Tax Margin-22.6%-1.4%1.8%1.6%2.1%
Income Tax Expense(27.86M)(6.52M)7.99M10.83M14.21M
Net Income(188.23M)(8.59M)23.08M14.39M22.92M
Net Margin-19.5%-0.6%1.4%0.8%1.1%
EPS (Basic)(1.77)(0.08)0.200.120.19
EPS (Diluted)(1.77)(0.08)0.190.110.18
Weighted Avg Shares107.84M110.7M116.73M119.4M122.18M
Weighted Avg Shares (Diluted)107.84M110.7M124.69M125.61M128.89M

Privia Health Group, Inc.

NASDAQ:PRVA

Intrinsic Alpha fair value

Locked

Current Price

$24.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.